Abstract 14690: ProduceRX Clinical Trial

Background: Nutrition related cardiometabolic diseases are leading causes of morbidity, health disparities and health care spending. Produce prescriptions are highly promising to address these issues but impacts on health outcomes have not been tested in a randomized controlled trial.

Hypothesis: A pre-randomized controlled trial that provides 6 months of free weekly produce deliveries to the intervention group reduces hemoglobin A1c (HbA1c), body mass index (BMI), and blood pressure (BP), among Medicaid patients with type 2 diabetes (T2DM) and persistently elevated HbA1c when compared to the control group.

Read the Full Abstract at Circulation 


Subscribe to our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.